Warner Chilcott Says FDA Has Approved MINASTRIN 24 FE
Warner Chilcott plc
(Nasdaq: WCRX) today announced that the United States Food and Drug
Administration (FDA) has approved MINASTRIN^TM 24 FE (norethindrone acetate
and ethinyl estradiol capsules and ferrous fumarate capsules) for the
prevention of pregnancy. MINASTRIN 24 FE is manufactured for Warner Chilcott
by a third party. The Company does not expect to be in a position to
commercially launch MINASTRIN 24 FE during 2013.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.